Primary Care
Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.
Recent Discussions
When do you restart antiplatelet therapy in patients with hemorrhagic conversion of stroke?
This is a great question and not an uncommon clinical encounter for stroke neurologists. Indeed there is no one right answer. First, you may want to make sure that the observed ICH is true transformation of an ischemic lesion. Second, the degree of hemorrhagic transformation matters, I totally agree...
Would you change treatment approach for rectal cancer with an associated intussusception?
If the patient has obstruction, I probably would favor surgery first. If not, then I'd treat it as usual. It's a judgment call though.
When do you incorporate Lyrica into the treatment strategy for patients with restless leg syndrome?
When it comes to treating RLS, my go-to medication is gabapentin. I rarely (and possibly could say never) prescribe dopamine agonists. Once you've treated one patient with augmentation and have seen the overwhelming discomfort it can cause a patient, you would likely feel how I feel about the dopami...
After completing 12 months romosozumab, what is the next best treatment option for patients with severe osteoporosis, high risk for fracture, and normal kidney function?
Zoledronic acid is my clear-cut first choice in this setting.
What features on CTA/MRA are most helpful for differentiating large vessel vasculitis from atherosclerosis?
While calcified plaque is not typically mistaken for large vessel vasculitis, distinguishing non-calcified atherosclerotic lesions from large vessel vasculitis is challenging. An experienced vascular radiologist is an invaluable resource in such situations if available. The first step is to assess ...
Would you recommend transition to hemodialysis for a patient with calciphylaxis, hyperphosphatemia, and ESKD on peritoneal dialysis?
Changing from PD to HD is a tough decision but I would do it for calcemic uremic arteriopathy CUA (calciphylaxis) for two reasons, increase clearance and guarantee IV delivery of sodium thiosulfate (STS). Peritoneal STS has been describedMataic & Bastani, PMID 16771254But I think CUA is life-threate...
Below what platelet count would you avoid using an AV fistula in a patient with ESKD and thrombocytopenia?
Great question & the answer is likely debatable based on personal experience. Review of some case reports show no evidence of prolonged bleeding after AVF cannulation with platelet counts as low as 37,000 (1). Platelet counts can drop by 5- 15% with initiation of HD normally. They fall during the fi...
Would you recommend avoiding PICC line placement in a kidney transplant patient with an estimated GFR of more than 45 ml/min/1.73m2 and no functional AV access?
Great question and of course there is no data to guide decision-making in this scenario. Anecdotally, I would assess the patient as a whole, not just limited to current GFR though that is a great starting point. What is their age and co-morbidities - is this a younger /middle-aged/older patient, is ...
What is your approach to managing insomnia in an ESKD patient?
I try to stay away from medication therapy. First, I recommend good sleep hygiene (i.e., avoiding coffee, watching TV while in bed, too much light, etc.). The next step would be recommending as much exercise (mainly walking) as possible. If I have to use medications, I would start with melatonin and...
Would you recommend oral or intravenous iron in a chronic kidney disease stage 4 patient who is not on an ESA and has a hemoglobin of 12.7 g/dl and an iron saturation of less than 20%?
I would not necessarily treat this patient with iron at all. I would check serum ferritin. If low would do a colonoscopy or look for causes of iron deficiency. If not low would observe. In general though for patients with CKD (not on dialysis yet) who need iron therapy, I would try oral iron first. ...